Literature DB >> 11368883

Analysis of the human CGB/LHB gene cluster in breast tumors by real-time quantitative RT-PCR assays.

Y Giovangrandi1, B Parfait, M Asheuer, M Olivi, R Lidereau, M Vidaud, I Bièche.   

Abstract

The six genes of the human chorionic gonadotropin beta subunit (CGB) and the gene of the luteinizing hormone beta subunit (LHB) are located in a cluster that spans 50 kb on chromosome 19q13.3. Only genes CGB7, B8, B5 and B3 can generate the human chorionic gonadotropin (hCG) beta molecule. The other two genes, CGB1 and B2, encode unidentified proteins. We have previously shown that malignant breast transformation is associated with the emergence of the 'trophoblastic' CGB genes (B8, B5 and B3), in addition to the CGB7 gene, which is the only CGB gene expressed in normal breast tissue. To better understand the dysregulation of the CGB/LHB gene cluster in breast cancer, we have developed real-time quantitative RT-PCR assays to analyze each subgroup of genes (the overall CGB genes, CGB1 and B2 together, and LHB alone) in 17 unilateral invasive primary breast tumor RNAs. We also analyzed the chorionic gonadotropin alpha (CGA) gene coding for the human CGA subunit. We found that the emergence of the 'trophoblastic' CGB genes in breast tumors is (i) accompanied by an increase in the total CGB mRNA steady-state level, (ii) mainly due to overexpression of genes CGB8, B5 and B3 (expression of other genes in the CGB/LHB gene cluster (CGB7, B2, B1 and LHB) changes little if at all), and (iii) not accompanied by overexpression of the CGA gene which is necessary to produce ectopic hCG heterodimeric hormone in breast tumor cells, these latter which yet expressed the LH/CG receptor. These observations suggest that it is mainly the CGB8, B5 and B3 genes which are upregulated in the 19q13.3 CGB gene cluster in breast tumors. They also point to a role (like growth factor) of the CGbeta subunit in breast tumorigenesis, via a novel pathway independent of the LH/CG receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368883     DOI: 10.1016/s0304-3835(01)00496-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Quantitative molecular assay for fingerprinting microbial communities of wastewater and estrogen-degrading consortia.

Authors:  Chang-Ping Yu; Rajiv Ahuja; Gary Sayler; Kung-Hui Chu
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

2.  Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma.

Authors:  Kristina Hotakainen; Susanna Lintula; Börje Ljungberg; Patrik Finne; Annukka Paju; Ulf-Håkan Stenman; Jakob Stenman
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

3.  Expression of beta-subunit of HCG genes during normal and failed pregnancy.

Authors:  Kristiina Rull; Maris Laan
Journal:  Hum Reprod       Date:  2005-08-25       Impact factor: 6.918

Review 4.  Genomics and genetics of gonadotropin beta-subunit genes: Unique FSHB and duplicated LHB/CGB loci.

Authors:  Liina Nagirnaja; Kristiina Rull; Liis Uusküla; Pille Hallast; Marina Grigorova; Maris Laan
Journal:  Mol Cell Endocrinol       Date:  2010-05-19       Impact factor: 4.102

5.  Human chorionic gonadotrophin beta expression in malignant Barrett's oesophagus.

Authors:  Anne Couvelard; François Paraf; Dominique Vidaud; Sylvie Dubois; Michel Vidaud; Jean-François Fléjou; Claude Degott
Journal:  Virchows Arch       Date:  2004-08-10       Impact factor: 4.064

6.  The evolution and genomic landscape of CGB1 and CGB2 genes.

Authors:  Pille Hallast; Kristiina Rull; Maris Laan
Journal:  Mol Cell Endocrinol       Date:  2006-10-19       Impact factor: 4.102

Review 7.  Human Chorionic Gonadotropin and Breast Cancer.

Authors:  Susanne Schüler-Toprak; Oliver Treeck; Olaf Ortmann
Journal:  Int J Mol Sci       Date:  2017-07-21       Impact factor: 5.923

8.  Human chorionic gonadotropin beta subunit genes CGB1 and CGB2 are transcriptionally active in ovarian cancer.

Authors:  Marta Kubiczak; Grzegorz P Walkowiak; Ewa Nowak-Markwitz; Anna Jankowska
Journal:  Int J Mol Sci       Date:  2013-06-17       Impact factor: 5.923

9.  Placental pseudo-malignancy from a DNA methylation perspective: unanswered questions and future directions.

Authors:  Boris Novakovic; Richard Saffery
Journal:  Front Genet       Date:  2013-12-10       Impact factor: 4.599

10.  Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.

Authors:  Tiziana de Cristofaro; Tina Di Palma; Amata Amy Soriano; Antonella Monticelli; Ornella Affinito; Sergio Cocozza; Mariastella Zannini
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.